Heart injury among hospitalized COVID-19 patients associated with higher risk of death
Watchdog Aims for Speedy Remdesivir Approval
How NPP Is Changing With the Onset of COVID-19
AstraZeneca Approached Gilead For Potential Merger - Report
AbbVie Announces Partnership To Develop Novel Covid-19 Antibody Therapy
AstraZeneca blood cancer drug shows signs of helping COVID-19 patients
Sorrento Therapeutics and Mount Sinai Health System
iBio – IBIO-201
Greenback Remains Soft Ahead of Employment Report, but Reversal Possible
What Are the Implications of Gilead’s Increased Focus on Oncology? 5-Star Analyst Weights In
Too Much Uncertainty Keeps This 5-Star Analyst Watching Amarin Stock From the Sidelines
Codiak BioSciences and the Ragon Institute of MGH, MIT, and Harvard
Tyson the alpaca takes heavyweight role in search for coronavirus vaccine
3 “Strong Buy” Penny Stocks That Could See Outsized Returns
After coronavirus, another hidden respiratory disease lurks in the buildings we left behind
AstraZeneca Partners With Accent To Develop Novel Cancer Treatments
Coronavirus pharma news roundup – 04/06/20
FDA clears emergency use of Roche test for COVID-19 ‘cytokine storm’
Wait for More Clarity Before Buying Gilead Stock, Says Analyst
Scientists tap the world's most powerful computers in the race to understand and stop the coronavirus
Estimating a US price tag of $5K per course, remdesivir is set to make billions for Gilead, says key analyst
3 "Strong Buy" Healthcare Stocks Under $5 With Big Upside Potential
BMS launches COVID-19 delayed MS drug Zeposia in US
Study panning anti-malaria drug Trump took against COVID faces new questions
This Analyst Thinks Menlo (MNLO) Stock Is Poised for Growth
Gilead’s next step on coronavirus
HCQ Misinformation Can Be Deadly: Let Patients Decide
Study finds COVID-19 convalescent plasma therapy safe, with 76% patients improving
Use of antihypertensive drugs generates pressure-packed debate in COVID-19 era
Lockdown: we need to experiment with reopenings now to prevent a second wave